Clinical Trial Update: Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating abatacept for common variable immunodeficiency with interstitial lung disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Variable Immunodeficiency
• Interstitial Lung Disease

Drugs mentioned

• Abatacept (abatacept)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Interstitial Lung Disease, Common Variable Immunodeficiency | Phase 2 | Status: RECRUITING